Search Within

Shutian Ruan

Formats
  1. Journal Article (35)
  2. Meeting Abstract (21)
Groups
  1. Sloan Kettering Institute Postdocs (56)
  2. Medical Physics (50)
  3. Radiology, Department of (43)
  4. GSK Faculty (40)
  5. Molecular Imaging and Therapy Service (39)
  6. Molecular Pharmacology and Chemistry Program Faculty (33)

More Groups

People
  1. Joseph O'Donoghue (33)
  2. Steven Larson (32)
  3. John Humm (30)
  4. Pat Zanzonico (24)
  5. Jorge Carrasquillo (19)
  6. Neeta Pandit-Taskar (19)

More People

Years
  1. 2023 (2)
  2. 2022 (4)
  3. 2020 (1)
  4. 2019 (4)
  5. 2018 (4)
  6. 2017 (3)

More Years

Publications
  1. Journal of Nuclear Medicine (19)
  2. Medical Physics (5)
  3. European Journal of Nuclear Medicine and Molecular Imaging (4)
  4. Cancer Research (3)
  5. Clinical Cancer Research (2)
  6. International Journal of Radiation Oncology, Biology, Physics (2)

More Publications

Publishers
  1. Society of Nuclear Medicine (19)
  2. American Association for Cancer Research (7)
  3. Springer (6)
  4. American Association of Physicists in Medicine (5)
  5. Elsevier Inc. (5)
  6. American Chemical Society (2)

More Publishers

Results (56)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pharmacokinetics and biodistribution of a [(86)Zr]Zr-DFO-MSTP2109A anti-STEAP1 antibody in metastatic castration-resistant prostate cancer patients
    Journal Article

    O'Donoghue, J. A.; Danila, D. C.; Pandit-Taskar, N.; Beylergil, V.; Cheal, S. M.; Fleming, S. E.; Fox, J. J.; Ruan, S.; Zanzonico, P. B.; Ragupathi, G.; more...
    Molecular Pharmaceutics (2019)

    Fulltext@MSK | Save
  • ImmunoPET imaging of endogenous and transfected prolactin receptor tumor xenografts
    Journal Article

    Cheal, S. M.; Ruan, S.; Veach, D. R.; Longo, V. A.; Punzalan, B. J.; Wu, J.; Fung, E. K.; Kelly, M. P.; Kirshner, J. R.; Giurleo, J. T.; more...
    Molecular Pharmaceutics (2018)

    Fulltext@MSK | Save
  • First-in-human human epidermal growth factor receptor 2-targeted imaging using (89)Zr-Pertuzumab PET/CT: Dosimetry and clinical application in patients with breast cancer
    Journal Article

    Ulaner, G. A.; Lyashchenko, S. K.; Riedl, C.; Ruan, S.; Zanzonico, P. B.; Lake, D.; Jhaveri, K.; Zeglis, B.; Lewis, J. S.; O'Donoghue, J. A.
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma
    Journal Article

    Carrasquillo, J. A.; O'Donoghue, J. A.; Beylergil, V.; Ruan, S.; Pandit-Taskar, N.; Larson, S. M.; Smith-Jones, P. M.; Lyashchenko, S. K.; Ohishi, N.; Ohtomo, T.; more...
    EJNMMI Research (2018)

    Fulltext@MSK | Save
  • Pharmacokinetics, biodistribution, and radiation dosimetry for (89)Zr-trastuzumab in patients with esophagogastric cancer
    Journal Article

    O'Donoghue, J. A.; Lewis, J. S.; Pandit-Taskar, N.; Fleming, S. E.; Schòˆder, H.; Larson, S. M.; Beylergil, V.; Ruan, S.; Lyashchenko, S. K.; Zanzonico, P. B.; more...
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • Biodistribution and radiation rose estimates for (89)Zr-DFO-HuMab-5B1 (MVT-2163) in CA19-9 positive cancer: First-in-man results
    Meeting Abstract

    O'Donoghue, J.; Lohrmann, C.; O'Reilly, E.; Yu, K.; Lowery, M.; Lyashchenko, S.; Pandit-Taskar, N.; Ruan, S.; Wu, L.; Teng, R.; more...
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • First-in-human study of (89)Zr-DFO-HuMab-5B1 (MVT-2163) PET/CT imaging with and without HuMab-5B1 (MVT-5873) in patients with pancreatic cancer and other CA 19-9 positive malignancies
    Meeting Abstract

    Lohrmann, C.; O'Reilly, E.; ODonoghue, J.; Yu, K. H.; Pandit-Taskar, N.; Lyashchenko, S.; Ruan, S.; Wu, J.; DeNoble, P.; Carrasquillo, J.; more...
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
    Journal Article

    Abou-Alfa, G. K.; Yen, C. J.; Hsu, C. H.; O'Donoghue, J.; Beylergil, V.; Ruan, S.; Pandit-Taskar, N.; Gansukh, B.; Lyashchenko, S. K.; Ma, J.; more...
    Cancer Chemotherapy and Pharmacology (2017)

    Fulltext@MSK | Save
  • First-in-human imaging with (89)Zr-Df-IAB2M Anti-PSMA minibody in patients with metastatic prostate cancer: Pharmacokinetics, biodistribution, dosimetry, and lesion uptake
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Ruan, S.; Lyashchenko, S. K.; Carrasquillo, J. A.; Heller, G.; Martinez, D. F.; Cheal, S. M.; Lewis, J. S.; Fleisher, M.; more...
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • A phase I/IIa trial of prostate specific membrane antigen (PSMA) positron emission tomography (PET) imaging with (89)Zr-Df-IAB2M in metastatic prostate cancer (PCa)
    Meeting Abstract

    Morris, M. J.; Martinez, D. F.; Durack, J. C.; Slovin, S. F.; Danila, D. C.; O'Donoghue, J. A.; Parada, N. A.; Lyashchenko, S. K.; Carrasquillo, J. A.; Ruan, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save